Insider Trading - Dyne Therapeutics Inc. (DYN)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Dyne Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-09-21
Purchase
2020-09-23
6:55 pm
Dyne Therapeutics Inc. DYN RA CAPITAL MANAGEMENT L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
660,000 $19 $12,540,000 2,805,045
(Indirect)
View
2020-09-21
Purchase
2020-09-23
7:09 pm
Dyne Therapeutics Inc. DYN Logos Global Management LP
10% Owner
700,000 $19 $13,300,000 1,504,392
(Indirect)
View
2020-09-21
Purchase
2020-09-23
7:11 pm
Dyne Therapeutics Inc. DYN VV Manager II LLC
Vida Ventures II LLC
VIDA VENTURES II-A LLC
10% Owner
815,000 $19 $15,485,000 79,921
(Indirect)
View
2021-09-20
Sale
2021-09-22
8:01 pm
Dyne Therapeutics Inc. DYN Beskrovnaya Oxana
Chief Scientific Officer
1,444 $15.9 $22,954 17,845
(Direct)
View
2021-09-20
Sale
2021-09-22
8:02 pm
Dyne Therapeutics Inc. DYN Brumm Joshua T
Director
8,009 $15.9 $127,312 99,018
(Direct)
View
2021-09-20
Sale
2021-09-22
8:02 pm
Dyne Therapeutics Inc. DYN McNeill Jonathan
See Remarks
1,274 $15.9 $20,252 35,636
(Direct)
View
2021-09-20
Sale
2021-09-22
8:03 pm
Dyne Therapeutics Inc. DYN Scalzo Richard William
See Remarks
859 $15.9 $13,655 10,606
(Direct)
View
2021-09-23
Sale
2021-09-24
10:50 am
Dyne Therapeutics Inc. DYN HIGH SUSANNA GATTI
COO
2,451 $17.22 $42,206 33,453
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-09-16
Option Award
2020-09-18
5:10 pm
N/A
2030-09-15
Dyne Therapeutics Inc. DYN Scalzo Richard William
See Remarks
47,040 $0 47,040
(Direct)
View
2020-09-16
Option Award
2020-09-18
5:11 pm
N/A
2030-09-15
Dyne Therapeutics Inc. DYN Brumm Joshua T
Director
427,808 $0 427,808
(Direct)
View
2020-09-16
Option Award
2020-09-18
5:11 pm
N/A
2030-09-15
Dyne Therapeutics Inc. DYN McNeill Jonathan
See Remarks
69,799 $0 89,697
(Direct)
View
2020-09-16
Option Award
2020-09-18
5:12 pm
N/A
2030-09-15
Dyne Therapeutics Inc. DYN Subramanian Romesh
Chief Scientific Officer
10% Owner
169,494 $0 694,434
(Direct)
View
2020-09-16
Option Award
2020-09-18
5:13 pm
N/A
2030-09-15
Dyne Therapeutics Inc. DYN Beskrovnaya Oxana
See Remarks
79,146 $0 79,146
(Direct)
View
2020-09-16
Option Award
2020-09-18
5:16 pm
N/A
2030-09-15
Dyne Therapeutics Inc. DYN HIGH SUSANNA GATTI
COO
147,309 $0 147,309
(Direct)
View
2020-07-31
Conversion
2020-09-23
6:55 pm
N/A
N/A
Dyne Therapeutics Inc. DYN HURWITZ EDWARD
Director
10% Owner
21,374,284 $0 16,514,062
(Indirect)
View
2020-09-21
Conversion
2020-09-23
6:55 pm
N/A
N/A
Dyne Therapeutics Inc. DYN RA CAPITAL MANAGEMENT L.P.
Kolchinsky Peter
Shah Rajeev M.
10% Owner
9,259,950 $0 2,805,045
(Indirect)
View
2020-09-21
Conversion
2020-09-23
6:56 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Atlas Venture Fund XI L.P.
Atlas Venture Associates XI L.P.
Atlas Venture Associates XI LLC
Atlas Venture Opportunity Fund I L.P.
Atlas Venture Associates Opportunity I L.P.
Atlas Venture Associates Opportunity I LLC
10% Owner
32,974,690 $0 1,608,785
(Indirect)
View
2020-09-21
Conversion
2020-09-23
6:56 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
6,944,964 $0 1,608,785
(Direct)
View
2020-07-31
Conversion
2020-09-23
6:59 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Kersten Dirk
Director
10% Owner
26,467,258 $0 26,467,258
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:00 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Rhodes Jason P
Director
32,974,690 $0 1,608,785
(Indirect)
View
2020-07-31
Conversion
2020-09-23
7:03 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Stehman-Breen Catherine
Director
46,299 $0 176,887
(Direct)
View
2020-07-31
Option Award
2020-09-23
7:03 pm
N/A
2030-07-30
Dyne Therapeutics Inc. DYN Stehman-Breen Catherine
Director
25,600 $0 176,887
(Direct)
View
2020-07-31
Conversion
2020-09-23
7:04 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Klein Lawrence Otto
Director
46,299 $0 71,899
(Direct)
View
2020-07-31
Option Award
2020-09-23
7:04 pm
N/A
2030-07-30
Dyne Therapeutics Inc. DYN Klein Lawrence Otto
Director
25,600 $0 71,899
(Direct)
View
2020-09-21
Conversion
2020-09-23
7:05 pm
N/A
N/A
Dyne Therapeutics Inc. DYN CureDuchenne Ventures LLC
10% Owner
2,602,972 $0 602,972
(Direct)
View
2020-09-21
Conversion
2020-09-23
7:06 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Forbion Capital Fund IV Cooperatief U.A.
10% Owner
26,467,258 $0 6,131,079
(Direct)
View
2020-09-21
Conversion
2020-09-23
7:09 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Logos Global Management LP
10% Owner
3,472,481 $0 1,504,392
(Indirect)
View
2020-07-31
Conversion
2020-09-23
7:10 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Lubner David Charles
Director
231,497 $0 257,097
(Direct)
View
2020-07-31
Option Award
2020-09-23
7:10 pm
N/A
2030-07-30
Dyne Therapeutics Inc. DYN Lubner David Charles
Director
25,600 $0 257,097
(Direct)
View
2020-09-21
Conversion
2020-09-23
7:11 pm
N/A
N/A
Dyne Therapeutics Inc. DYN VV Manager II LLC
Vida Ventures II LLC
VIDA VENTURES II-A LLC
10% Owner
9,259,951 $0 79,921
(Indirect)
View
2020-09-21
Conversion
2020-09-23
7:12 pm
N/A
N/A
Dyne Therapeutics Inc. DYN MPM BIOVENTURES 2018 L.P.
MPM BIOVENTURES 2018 (B) L.P.
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC
MPM BioVentures 2018 GP LLC
MPM BioVentures 2018 LLC
EVNIN LUKE
Foley Todd
GADICKE ANSBERT
10% Owner
21,374,284 $0 91,081
(Indirect)
View
2021-03-02
Option Award
2021-03-04
7:24 pm
N/A
2031-03-01
Dyne Therapeutics Inc. DYN Farwell Wildon
Chief Medical Officer
300,000 $0 300,000
(Direct)
View
2021-05-26
Option Award
2021-05-27
8:37 pm
N/A
2031-05-25
Dyne Therapeutics Inc. DYN Lubner David Charles
Director
19,596 $0 19,596
(Direct)
View
2021-05-26
Option Award
2021-05-27
8:38 pm
N/A
2031-05-25
Dyne Therapeutics Inc. DYN Rhodes Jason P
Director
19,596 $0 19,596
(Direct)
View
2021-05-26
Option Award
2021-05-27
8:38 pm
N/A
2031-05-25
Dyne Therapeutics Inc. DYN HURWITZ EDWARD
Director
19,596 $0 19,596
(Direct)
View
2021-05-26
Option Award
2021-05-27
8:38 pm
N/A
2031-05-25
Dyne Therapeutics Inc. DYN Klein Lawrence Otto
Director
19,596 $0 19,596
(Direct)
View
2021-05-26
Option Award
2021-05-27
8:38 pm
N/A
2031-05-25
Dyne Therapeutics Inc. DYN Kersten Dirk
Director
10% Owner
19,596 $0 19,596
(Direct)
View
2021-05-26
Option Award
2021-05-27
8:43 pm
N/A
2031-05-25
Dyne Therapeutics Inc. DYN Stehman-Breen Catherine
Director
19,596 $0 19,596
(Direct)
View
2021-06-02
Option Award
2021-06-02
6:41 pm
N/A
2031-06-01
Dyne Therapeutics Inc. DYN Beskrovnaya Oxana
Chief Scientific Officer
110,000 $0 110,000
(Direct)
View
2021-07-10
Option Award
2021-07-13
4:22 pm
N/A
2031-07-09
Dyne Therapeutics Inc. DYN McNeill Jonathan
See Remarks
25,000 $0 25,000
(Direct)
View
2021-07-13
Other
2021-07-15
4:33 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Atlas Venture Fund XI L.P.
10% Owner
814,013 $0 8,140,130
(Direct)
View
2021-10-01
Gift
2021-10-04
5:03 pm
N/A
N/A
Dyne Therapeutics Inc. DYN Brumm Joshua T
Director
3,500 $0 95,518
(Direct)
View